Scutebarbatine X is primarily studied for its potential neuroprotective properties. It has shown promise in modulating neuronal activity, particularly in models of neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases. Research indicates it may help reduce oxidative stress and inflammation in brain tissues, supporting neuron survival and function. It is also being explored for its anxiolytic and antidepressant-like effects in preclinical studies, suggesting possible use in treating mood disorders. Due to its ability to cross the blood-brain barrier effectively, it is considered a candidate for central nervous system-targeted therapies. Current applications remain in the experimental stage, mainly within academic and pharmaceutical research settings.